malondialdehyde has been researched along with Schizophrenia in 58 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.45) | 18.7374 |
| 1990's | 2 (3.45) | 18.2507 |
| 2000's | 15 (25.86) | 29.6817 |
| 2010's | 28 (48.28) | 24.3611 |
| 2020's | 11 (18.97) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Y; Huang, X; Lang, X; Li, Z; Liu, Z; Lv, Q; Sultana, MS; Wu, K; Yi, Z; Zhu, M | 1 |
| Kostina, OV; Mazo, GE; Piatoikina, AS; Shcherbatyuk, TG; Zhilyaeva, TV; Zhukova, ES | 1 |
| Chen, N; Chen, S; Sun, Y; Wei, C; Xiu, M; Zhang, X | 1 |
| Carvalho, AF; Kanchanatawan, B; Maes, M; Sirivichayakul, S | 2 |
| Fan, Y; Geng, D; Lang, X; Li, Z; Lv, Q; Wu, K; Yi, Z; Zhao, L; Zhu, S | 1 |
| Barbosa, DS; Carvalho, AF; de Lima Pedrão, JV; de Oliveira Semeão, L; Geffard, M; Kanchanatawan, B; Maes, A; Maes, M; Matsumoto, AK; Michelin, AP; Moreira, EG; Sirivichayakul, S | 1 |
| Chen, DC; Chen, S; Curbo, ME; Li, Z; Tan, SP; Tong, YS; Wu, HE; Xiu, MH; Zhang, XY | 1 |
| Bryll, A; Karcz, P; Kozicz, T; Krzyściak, W; Pilecki, M; Popiela, TJ; Skrzypek, J; Śmierciak, N; Szwajca, M | 1 |
| Ayadi, F; Ben Thabet, J; Charfi, N; Grayaa, S; Guidara, W; Maalej, M; Messedi, M; Naifar, M; Omri, S | 1 |
| Guan, HY; Wang, X; Wu, ZW; Xiu, MH; Yu, HH; Zhang, XY | 1 |
| Blagonravova, AS; Kasyanov, ED; Kostina, OV; Lyakhova, AA; Mazo, GE; Piatoikina, AS; Semennov, IV; Shcherbatyuk, TG; Zhilyaeva, TV; Zhukova, ES | 1 |
| Aderibigbe, AO; Ajayi, AM; Ben-Azu, B; Iwalewa, EO; Omogbiya, IA; Umukoro, S | 1 |
| Abdel-Sattar, SA; Ahmed, HI; Zaky, HS | 1 |
| Bai, ZL; Chen, GY; Chen, X; Cheng, Y; Deng, W; Du, Y; Li, XS; Wei, ZX; Zheng, GE | 1 |
| An, H; Cassidy, RM; Du, X; Huang, X; Huang, XF; Jia, Q; Ning, Y; Qi, L; Soares, JC; Wang, L; Xiao, C; Yin, G; Zhang, XY | 1 |
| Asemi, Z; Bahmani, F; Banafshe, HR; Ghaderi, A; Karimi, MA; Mehrzad, F; Mirhosseini, N; Moradi, M | 1 |
| Canales-Aguirre, A; Cerdán-Sánchez, LF; Estarrón-Espinosa, M; Gómez-Pinedo, U; Medina-Hernández, V; Ramos-Loyo, J | 1 |
| Balslev Jorgensen, M; Broedbaek, K; Fink-Jensen, A; Greisen Soendergaard, M; Henriksen, T; Jepsen, P; Jorgensen, A; Knorr, U; Lykkesfeldt, J; Poulsen, HE; Weimann, A | 1 |
| Cao, X; Hou, Y; Liu, Y; Mao, Z; Wu, C; Xie, G; Yang, J; Zhang, H; Zhao, Y | 1 |
| Bošković, M; Grabnar, I; Kores Plesničar, B; Terzič, T; Vovk, T | 1 |
| Borella, VC; de Lucena, DF; de Menezes, AT; de Sousa, FC; do Carmo, MR; Freire, RS; Gama, CS; Gomes, PX; Macêdo, D; Monte, AS; Ribeiro, BM; Rocha, NF; Vale, ML | 1 |
| Binatti, AR; Budni, J; Chipindo, HL; da Rosa Silveira, F; de Oliveira, MB; Gama, CS; Heylmann, AS; Maravai, SG; Mastella, GA; Panizzutti, B; Quevedo, J; Schuck, PF; Steckert, AV; Volpato, AM; Wessler, PG; Zugno, AI | 1 |
| Ivanišević, J; Kotur-Stevuljević, J; Miljković, M; Milovanović, S; Spasić, S; Stefanović, A; Vidović, B; Ðorđević, B | 1 |
| Akyol, O; Kus, I; Ozyurt, B; Ozyurt, H; Sarsilmaz, M; Songur, A | 1 |
| Chen, DC; Soares, JC; Tan, S; Tan, YL; Wang, Z; Wu, JQ; Yang, F; Zhang, XY | 1 |
| Aydemir, O; Brown, EC; Brüne, M; Cubukcoglu, Z; Erdin, S; Esen-Danaci, A; Gonzalez-Liencres, C; Onur, E; Tas, C | 1 |
| Chen, DC; Okusaga, OO; Soares, JC; Tan, SP; Tan, YL; Wang, ZR; Yang, FD; Zhang, XY; Zunta-Soares, GB | 1 |
| Costa E Silva, J; Kalia, M | 1 |
| de Lucena, DF; de Sousa, CN; Gama, CS; Lima, LL; Macêdo, D; Oliveira, Tde Q; Vasconcelos, GS; Vasconcelos, SM; Ximenes, NC | 1 |
| Devanarayanan, S; Kattimani, S; Nandeesha, H; Sarkar, S | 1 |
| Budni, J; Calixto, OP; Canever, L; Damázio, LS; de Oliveira, MB; Heylmann, AS; Macan, TP; Mastella, GA; Pacheco, FD; Pedro, TH; Pereira, FP; Quevedo, J; Schuck, PF; Steckert, A; Wessler, PG; Zugno, AI | 1 |
| El-Sayed El-Sayad, M; El-Sayed El-Sisi, A; Osman, EY; Sayed Ramadan, E; Sokkar, SS | 1 |
| Bahn, S; Bernstein, HG; Brigadski, T; Dobrowolny, H; Frodl, T; Guest, PC; Isermann, B; Jordan, W; Lessmann, V; Pilz, J; Rodenbeck, A; Schiltz, K; Schwedhelm, E; Steiner, J; Tumani, H; Wiltfang, J | 1 |
| Ahmed, FA; Al-Chalabi, BM; Thanoon, IA | 1 |
| Gryzunov, IuA; Gurovich, IIa; Kalinina, VV; Misionzhnik, EIu; Moskvitina, TA; Shevchenko, VA; Shmukler, AB; Smolina, NV; Sokolova, TN; Uzbekov, MG | 1 |
| Ciobica, A; Dobrin, I; Padurariu, M; Stefanescu, C | 1 |
| Karabulut, AB; Kartalci, S; Ozcan, AC; Porgali, E; Unal, S | 1 |
| Ciobica, A; Dobrin, I; Dobrin, R; Padurariu, M; Stefanescu, C | 1 |
| Akiibinu, MO; Ogundahunsi, OA; Ogunyemi, EO | 1 |
| Andrade, GM; Carvalho, AC; Magalhães, HI; Moraes, MO; Morais, TC; Nobre-Júnior, HV; Rao, VS; Santos, FA; Trevisan, MT | 1 |
| Dakhale, G; Khanzode, S; Khobragade, L; Saoji, A; Turankar, A | 1 |
| Bleich, S; Degner, D; Emrich, HM; Hajak, G; Kern, V; Kornhuber, J; Kropp, S; Lange, K; Rüther, E; Schneider, U | 1 |
| Cao, LY; Shen, Y; Tan, YL; Wu, GY; Xu, Q; Zhang, XY; Zhou, DF | 1 |
| García-Estrada, J; Luquin, S; Medina-Hernández, V; Navarro-Ruiz, A; Ramos-Loyo, J; Sánchez, LF | 1 |
| Chianetta, JM; Grignon, S | 1 |
| Cao, LY; Haile, CN; Kosten, TA; Kosten, TR; Tan, YL; Wu, GY; Zhang, XY; Zhou, DF | 2 |
| Akkaya, C; Altin, A; Demirci, M; Kirli, S; Sarandol, A; Sarandol, E | 1 |
| Gursoy, B; Kirli, S; Sarandöl, E; Sipahioglu, D; Sivrioglu, EY | 1 |
| Akkaya, C; Eroz, E; Kirli, S; Ocak, N; Sarandol, A; Sarandol, E | 1 |
| Gulidova, GP | 1 |
| Frolov, VM; Kut'ko, II; Pavlenko, VV; Pustovoĭ, IuG; Rachkauskas, GS | 1 |
| Correnti, EE; Mahadik, JS; Mahadik, SP; Mukherjee, S; Scheffer, R | 1 |
| Akçay, F; Aksoy, H; Altuntas, I; Cayköylü, A; Coskun, I | 1 |
| Agarwal, AK; Barthwal, MK; Dalal, PK; Dikshit, M; Nag, D; Seth, PK; Srimal, RC; Srivastava, N | 1 |
| Atmaca, M; Canatan, H; Cinkilinc, N; Kuloglu, M; Tezcan, AE; Ustundag, B | 1 |
| Bindoli, A; Cavallini, L; Dalla Libera, A; Galzigna, L; Rigobello, MP | 1 |
2 review(s) available for malondialdehyde and Schizophrenia
| Article | Year |
|---|---|
Biomarkers of psychiatric diseases: current status and future prospects.
Topics: Acetyltransferases; Alzheimer Disease; Biomarkers; Bipolar Disorder; Brain; Brain-Derived Neurotrophic Factor; C-Reactive Protein; Cytokines; Depressive Disorder, Major; Dopamine; gamma-Aminobutyric Acid; History, 20th Century; Humans; Isoprostanes; Malondialdehyde; Mental Disorders; Mood Disorders; Neopterin; Neurofibrillary Tangles; S100 Calcium Binding Protein beta Subunit; Schizophrenia; Suicidal Ideation | 2015 |
Oxidative stress in schizophrenia - focusing on the main markers.
Topics: Aldehydes; Animals; Antioxidants; Antipsychotic Agents; Biomarkers; Catalase; Free Radicals; Glutathione Peroxidase; Humans; Lipid Peroxidation; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Rats; Reactive Oxygen Species; Schizophrenia; Superoxide Dismutase | 2011 |
6 trial(s) available for malondialdehyde and Schizophrenia
| Article | Year |
|---|---|
Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients.
Topics: Adult; Antioxidants; Dietary Supplements; Double-Blind Method; Female; Humans; Insulin Resistance; Iran; Male; Malondialdehyde; Middle Aged; Probiotics; Schizophrenia; Vitamin D; Vitamins | 2019 |
Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Ascorbic Acid; Brief Psychiatric Rating Scale; Case-Control Studies; Chi-Square Distribution; Female; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Prospective Studies; Schizophrenia; Superoxide Dismutase | 2004 |
Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Ascorbic Acid; Carotenoids; Case-Control Studies; Female; Humans; Male; Malondialdehyde; Middle Aged; Nerve Growth Factors; Oxidative Stress; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Schizophrenia; Superoxide Dismutase; Vitamin E | 2007 |
The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Antioxidants; Antipsychotic Agents; Ascorbic Acid; Erythrocytes; Fatty Acids, Omega-3; Female; Haloperidol; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Pilot Projects; Schizophrenia; Schizophrenic Psychology; Superoxide Dismutase; Treatment Outcome; Vitamin E | 2007 |
[Antioxidants in the treatment of schizophrenia (the correction of lipid peroxidation processes)].
Topics: Adult; Antioxidants; Antipsychotic Agents; Drug Therapy, Combination; Female; Free Radicals; Humans; Lipid Peroxidation; Lipid Peroxides; Male; Malondialdehyde; Middle Aged; Recurrence; Schizophrenia | 1996 |
Elevated plasma lipid peroxides at the onset of nonaffective psychosis.
Topics: Adult; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Lipid Peroxides; Male; Malondialdehyde; Psychiatric Status Rating Scales; Psychotic Disorders; Schizoid Personality Disorder; Schizophrenia; Thiobarbituric Acid Reactive Substances | 1998 |
50 other study(ies) available for malondialdehyde and Schizophrenia
| Article | Year |
|---|---|
Sex difference in the interrelationship between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia.
Topics: Female; Humans; Male; Malondialdehyde; Oxidative Stress; Schizophrenia; Sex Characteristics; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2021 |
Gender-related Characteristics of Oxidative Stress Severity and Cognitive Impairment in Patients With Schizophrenia.
Topics: Antioxidants; Catalase; Cognitive Dysfunction; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Schizophrenia; Sex Factors; Superoxide Dismutase | 2023 |
Interaction of oxidative stress and BDNF on executive dysfunction in patients with chronic schizophrenia.
Topics: Adult; Biomarkers; Brain-Derived Neurotrophic Factor; China; Cognition Disorders; Cognitive Dysfunction; Executive Function; Female; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Neuropsychological Tests; Oxidative Stress; Schizophrenia; Superoxide Dismutase | 2020 |
In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde.
Topics: Humans; Immunoglobulin M; Malondialdehyde; Memory Disorders; Neuropsychological Tests; Psychotic Disorders; Schizophrenia | 2020 |
Interaction between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia.
Topics: Adult; Female; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Oxidative Stress; Schizophrenia; Tumor Necrosis Factor-alpha; Young Adult | 2020 |
Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity.
Topics: Adolescent; Adult; Aged; Antibody Specificity; Antipsychotic Agents; Aryldialkylphosphatase; Body Mass Index; Female; Humans; Immunity, Innate; Immunoglobulin M; Interleukin-4; Interleukin-6; Least-Squares Analysis; Logistic Models; Male; Malondialdehyde; Middle Aged; Neurocognitive Disorders; Neuroimmunomodulation; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Socioeconomic Factors; Tumor Necrosis Factor-alpha; Young Adult | 2020 |
Interrelationships Between BDNF, Superoxide Dismutase, and Cognitive Impairment in Drug-Naive First-Episode Patients With Schizophrenia.
Topics: Adult; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Female; Humans; Male; Malondialdehyde; Schizophrenia; Superoxide Dismutase; Young Adult | 2020 |
The Relationship between the Level of Anterior Cingulate Cortex Metabolites, Brain-Periphery Redox Imbalance, and the Clinical State of Patients with Schizophrenia and Personality Disorders.
Topics: Adult; Antioxidants; Aspartic Acid; Female; Glutamic Acid; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Malondialdehyde; Oxidants; Oxidation-Reduction; Oxidative Stress; Personality Disorders; Prognosis; Psychotic Disorders; Schizophrenia; Young Adult | 2020 |
Predictive value of oxidative stress biomarkers in drug‑free patients with schizophrenia and schizo-affective disorder.
Topics: Adult; Advanced Oxidation Protein Products; Biomarkers; Case-Control Studies; Female; Glutathione; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Mood Disorders; Oxidation-Reduction; Oxidative Stress; Psychotic Disorders; ROC Curve; Schizophrenia; Sensitivity and Specificity; Tunisia | 2020 |
Interrelationships Between Oxidative Stress, Cytokines, and Psychotic Symptoms and Executive Functions in Patients With Chronic Schizophrenia.
Topics: Cytokines; Executive Function; Humans; Malondialdehyde; Oxidative Stress; Schizophrenia; Superoxide Dismutase | 2021 |
Association of antioxidant deficiency and the level of products of protein and lipid peroxidation in patients with the first episode of schizophrenia.
Topics: Antioxidants; Catalase; Glutathione Peroxidase; Humans; Lipid Peroxidation; Malondialdehyde; Oxidative Stress; Schizophrenia; Superoxide Dismutase | 2022 |
Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways.
Topics: Acetylcholinesterase; Animals; Antipsychotic Agents; Catalase; Disease Models, Animal; Doxycycline; Excitatory Amino Acid Antagonists; Exploratory Behavior; Glutathione; Ketamine; Male; Malondialdehyde; Maze Learning; Mice; Nitroprusside; Oxidative Stress; Recognition, Psychology; Risperidone; Schizophrenia; Signal Transduction; Superoxide Dismutase | 2018 |
Vinpocetine halts ketamine-induced schizophrenia-like deficits in rats: impact on BDNF and GSK-3β/β-catenin pathway.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; beta Catenin; Brain-Derived Neurotrophic Factor; Glycogen Synthase Kinase 3 beta; Hippocampus; Ketamine; Male; Malondialdehyde; Oxidative Stress; Rats, Sprague-Dawley; Schizophrenia; Signal Transduction; Vinca Alkaloids | 2018 |
Serum Oxidative Stress Marker Levels in Unmedicated and Medicated Patients with Schizophrenia.
Topics: Adult; Antipsychotic Agents; Biomarkers; Female; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Oxidative Stress; Schizophrenia; Superoxide Dismutase | 2018 |
Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients.
Topics: Antipsychotic Agents; Body Mass Index; Cross-Sectional Studies; Female; Humans; Male; Malondialdehyde; Middle Aged; Obesity; Oxidative Stress; Schizophrenia | 2018 |
In Schizophrenia, Increased Plasma IgM/IgA Responses to Gut Commensal Bacteria Are Associated with Negative Symptoms, Neurocognitive Impairments, and the Deficit Phenotype.
Topics: Adult; Antibodies, Bacterial; Case-Control Studies; Dicarboxylic Acids; Female; Gastrointestinal Microbiome; Humans; Immunoglobulin A; Immunoglobulin M; Male; Malondialdehyde; Schizophrenia; Schizophrenic Psychology | 2019 |
Sex differences in lipid peroxidation and fatty acid levels in recent onset schizophrenia.
Topics: Adolescent; Adult; Aldehydes; Analysis of Variance; Arachidonic Acid; Chromatography; Docosahexaenoic Acids; Eicosapentaenoic Acid; Erythrocyte Membrane; Erythrocytes; Fatty Acids; Female; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenia, Paranoid; Sex Characteristics; Young Adult | 2013 |
Increased systemic oxidatively generated DNA and RNA damage in schizophrenia.
Topics: Adult; Case-Control Studies; Deoxyguanosine; DNA Damage; Female; Guanosine; Humans; Hydrocortisone; Male; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Retrospective Studies; RNA; Saliva; Schizophrenia; Young Adult | 2013 |
Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice.
Topics: Animals; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Hippocampus; Immobility Response, Tonic; Ketamine; Male; Malondialdehyde; Maze Learning; Mice; Microglia; Motor Activity; Nerve Degeneration; Nitric Oxide; Nitric Oxide Synthase; Prefrontal Cortex; Recognition, Psychology; Schizophrenia; Superoxide Dismutase | 2013 |
Oxidative stress in schizophrenia patients treated with long-acting haloperidol decanoate.
Topics: Adult; Antioxidants; Antipsychotic Agents; Basal Ganglia Diseases; Catalase; Female; Glutathione; Glutathione Peroxidase; Haloperidol; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Psychopathology; Schizophrenia; Severity of Illness Index; Superoxide Dismutase | 2013 |
Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: reversal by clozapine.
Topics: Age Factors; Animals; Animals, Newborn; Antipsychotic Agents; Brain; Clozapine; Developmental Disabilities; Disease Models, Animal; Lipid Peroxidation; Male; Malondialdehyde; Maze Learning; Microglia; Nitric Oxide Synthase Type II; Oxidative Stress; Poly I-C; Rats; Rats, Wistar; Reflex, Startle; Schizophrenia | 2013 |
Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia.
Topics: Animals; Brain; Brain Injuries; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Acids, Omega-3; Glutathione Peroxidase; Ketamine; Male; Malondialdehyde; Mental Disorders; Oxidative Stress; Protein Carbonylation; Rats; Rats, Wistar; Schizophrenia; Sensory Gating; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2014 |
Associations of oxidative stress status parameters with traditional cardiovascular disease risk factors in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Apolipoproteins; Blood Glucose; Cardiovascular Diseases; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Fasting; Female; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Prognosis; Risk Factors; Schizophrenia; Triglycerides | 2014 |
Potential role of some oxidant/antioxidant status parameters in prefrontal cortex of rat brain in an experimental psychosis model and the protective effects of melatonin.
Topics: Animals; Antioxidants; Disease Models, Animal; Dizocilpine Maleate; Glutathione Peroxidase; Male; Malondialdehyde; Melatonin; Oxidants; Oxidative Stress; Prefrontal Cortex; Psychotic Disorders; Rats; Rats, Wistar; Reactive Oxygen Species; Schizophrenia; Superoxide Dismutase | 2014 |
Association of altered CuZn superoxide dismutase and cognitive impairment in schizophrenia patients with tardive dyskinesia.
Topics: Adult; Aged; Antioxidants; Case-Control Studies; Cognition Disorders; Humans; Male; Malondialdehyde; Middle Aged; Movement Disorders; Neuropsychological Tests; Psychiatric Status Rating Scales; Schizophrenia; Statistics, Nonparametric; Superoxide Dismutase | 2014 |
Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition.
Topics: Adolescent; Adult; Antioxidants; Biomarkers; Case-Control Studies; Cognition; Female; Glutathione; Homocysteine; Humans; Male; Malondialdehyde; Middle Aged; Nerve Growth Factors; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species; Schizophrenia; Schizophrenic Psychology; Social Behavior; Superoxide Dismutase; Young Adult | 2014 |
The interplay between BDNF and oxidative stress in chronic schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Catalase; Female; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Superoxide Dismutase | 2015 |
Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms.
Topics: Analysis of Variance; Animals; Antioxidants; Antipsychotic Agents; Brain; Brain-Derived Neurotrophic Factor; Clozapine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Excitatory Amino Acid Antagonists; Exploratory Behavior; Glutathione; Interpersonal Relations; Ketamine; Lipid Peroxidation; Male; Malondialdehyde; Maze Learning; Mice; Nitrites; Random Allocation; Reflex, Startle; Schizophrenia; Thioctic Acid | 2015 |
Relationship between matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia: a case control study.
Topics: Adult; Case-Control Studies; Humans; Linear Models; Male; Malondialdehyde; Matrix Metalloproteinase 9; Models, Biological; Oxidative Stress; Schizophrenia | 2016 |
Effect of folic acid on oxidative stress and behavioral changes in the animal model of schizophrenia induced by ketamine.
Topics: Animals; Attention Deficit and Disruptive Behavior Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Folic Acid; Interpersonal Relations; Ketamine; Lipid Metabolism; Locomotion; Male; Malondialdehyde; Oxidative Stress; Protein Carbonylation; Rats; Rats, Wistar; Schizophrenia; Superoxide Dismutase; Time Factors; Vitamin B Complex | 2016 |
Celecoxib and omega-3 fatty acids alone and in combination with risperidone affect the behavior and brain biochemistry in amphetamine-induced model of schizophrenia.
Topics: Amphetamine; Animals; Behavior, Animal; Brain; Celecoxib; Disease Models, Animal; Drug Therapy, Combination; Fatty Acids, Omega-3; Male; Malondialdehyde; Maze Learning; Rats; Risperidone; Schizophrenia; Tumor Necrosis Factor-alpha | 2016 |
Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders.
Topics: Adult; Depressive Disorder, Major; Dinoprost; Female; Follow-Up Studies; Glutathione Transferase; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Psychiatric Status Rating Scales; Schizophrenia; Statistics, Nonparametric; Superoxide Dismutase | 2018 |
Potential effect of olanzapine on total antioxidant status and lipid peroxidation in schizophrenic patients.
Topics: Adolescent; Adult; Analysis of Variance; Antioxidants; Antipsychotic Agents; Benzodiazepines; Humans; Lipid Peroxidation; Malondialdehyde; Olanzapine; Schizophrenia; Young Adult | 2009 |
[Disturbance of monoaminooxidase activity and indices of endogenous intoxication in patients with the first episode of schizophrenia].
Topics: Adult; Blood Platelets; Data Interpretation, Statistical; Female; Humans; Lipid Peroxidation; Male; Malondialdehyde; Monoamine Oxidase; Patient Selection; Regression Analysis; Schizophrenia; Serum Albumin | 2009 |
Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics.
Topics: Adult; Antioxidants; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Glutathione Peroxidase; Haloperidol; Humans; Lipid Peroxidation; Malondialdehyde; Middle Aged; Olanzapine; Oxidative Stress; Quetiapine Fumarate; Risperidone; Schizophrenia; Superoxide Dismutase | 2010 |
Acute and chronic effects of electroconvulsive treatment on oxidative parameters in schizophrenia patients.
Topics: Adult; Antioxidants; Catalase; Electroconvulsive Therapy; Female; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Schizophrenia; Time Factors; Treatment Outcome; Young Adult | 2011 |
Inter-relationship of plasma markers of oxidative stress and thyroid hormones in schizophrenics.
Topics: Adult; Biomarkers; Case-Control Studies; Female; Humans; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Peroxides; Schizophrenia; Thyroid Gland; Thyroid Hormones; Thyrotropin | 2012 |
Mangiferin ameliorates 6-hydroxydopamine-induced cytotoxicity and oxidative stress in ketamine model of schizophrenia.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Behavior, Animal; Brain; Cell Death; Cell Survival; Cells, Cultured; Female; Interleukin-6; Ketamine; Lipid Peroxidation; Male; Malondialdehyde; Mesencephalon; Mice; Motor Activity; Neuroprotective Agents; Neurotoxins; Nitrites; Oxidative Stress; Oxidopamine; Rats; Rats, Wistar; Schizophrenia; Xanthones | 2012 |
Oxidative stress during treatment with first- and second-generation antipsychotics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Chromatography, High Pressure Liquid; Female; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Psychiatric Status Rating Scales; Schizophrenia | 2005 |
Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Catalase; Clozapine; Female; Free Radicals; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Superoxide Dismutase | 2006 |
Increased lipid peroxidation and neuron specific enolase in treatment refractory schizophrenics.
Topics: Adult; Aldehydes; Antipsychotic Agents; Brief Psychiatric Rating Scale; Drug Resistance; Female; Humans; Lipid Peroxidation; Male; Malondialdehyde; Neurons; Oxidative Stress; Phosphopyruvate Hydratase; Schizophrenia; Schizophrenic Psychology | 2007 |
Assessment of malondialdehyde levels in schizophrenia: a meta-analysis and some methodological considerations.
Topics: Humans; Malondialdehyde; Meta-Analysis as Topic; PubMed; Reproducibility of Results; Retrospective Studies; Schizophrenia; Selection Bias | 2007 |
Nicotine dependence, symptoms and oxidative stress in male patients with schizophrenia.
Topics: Adult; Analysis of Variance; Behavioral Symptoms; Catalase; Chi-Square Distribution; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Superoxide Dismutase; Tobacco Use Disorder | 2007 |
Disrupted antioxidant enzyme activity and elevated lipid peroxidation products in schizophrenic patients with tardive dyskinesia.
Topics: Adult; Case-Control Studies; Catalase; Dyskinesia, Drug-Induced; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Schizophrenia; Superoxide Dismutase | 2007 |
Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Aryldialkylphosphatase; C-Reactive Protein; Carboxylic Ester Hydrolases; Coronary Artery Disease; Female; Humans; Leptin; Lipoproteins; Male; Malondialdehyde; Oxidation-Reduction; Risk Factors; Schizophrenia; Triglycerides; Tumor Necrosis Factor-alpha | 2007 |
[Role of peroxides in changes in brain mitochondria energy metabolism following exposure to schizophrenic patients' serum].
Topics: Animals; Antioxidants; Cats; Cerebral Cortex; Energy Metabolism; Glutathione; Humans; Immune Sera; In Vitro Techniques; Malondialdehyde; Mitochondria; Peroxides; Schizophrenia | 1981 |
Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients.
Topics: Adolescent; Adult; Age Factors; Case-Control Studies; Erythrocytes; Female; Free Radicals; Glutathione; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Schizophrenia; Superoxide Dismutase; Time Factors | 2000 |
Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients.
Topics: Adolescent; Adult; Antioxidants; Blood Platelets; Catalase; Female; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Neutrophils; Nitrites; Schizophrenia; Superoxide Dismutase | 2001 |
Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder.
Topics: Antioxidants; Bipolar Disorder; Glutathione Peroxidase; Humans; Lipid Peroxidation; Malondialdehyde; Schizophrenia; Superoxide Dismutase | 2002 |
Decrease of serum malondialdehyde in patients treated with chlorpromazine.
Topics: Adult; Aged; Chlorpromazine; Depression, Chemical; Humans; Male; Malonates; Malondialdehyde; Middle Aged; Schizophrenia; Spectrophotometry, Infrared | 1987 |